EISSN 2475-0581

IMPACT FACTOR: 0.6 INDEXED IN SCI EXPANDED INDEXED IN PUBMED

Psychiatry and Clinical Psychopharmacology

35 141 2025

HIGHLY CITED ARTICLES

Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria

Danışman et al.

Association Between Mood Disorder Severity, Treatment Response and Systemic Inflammatory Markers: Exploring the Role of NLR, PLR, MLR, and SII

Kucukkarapınar et al.

Experiential Avoidance Process Model: A Review of the Mechanism for the Generation and Maintenance of Avoidance Behavior

Wang et al.

Editorial

Triple reuptake inhibitors (TRIs): do they promise us a rose garden?

Samet Kose ¹ , Mesut Cetin ²

Author Affiliation(s)

1.

Psychiatry & Clinical Psychopharmacology, Academic Editor of Psychiatry and Behavioral Sciences, Franklin, TN, USA

2.

Psychiatry & Clinical Psychopharmacology and Journal of Mood Disorders, Istanbul, Turkey

Psychiatry and Clinical Psychopharmacology 2018; 28: 119-122

DOI: 10.1080/24750573.2018.1443386

Read: 26 Downloads: 15 Published: 01 June 2018

Volume 28, Issue 2, June 2018

Previous Article

Files